Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection

Histone methyltransferases are important determinants of the initiation and progression of hepatocellular carcinoma (HCC) and represent promising therapeutic targets. However, whether the expression profile of multiple histone methyltransferases represents a poorer prognosis is entirely unknown. The...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2018-09, Vol.16 (3), p.3665-3673
Main Authors: Lin, Zhifei, Jia, Huliang, Hong, Liang, Zheng, Yahui, Shao, Weiqin, Ren, Xudong, Zhu, Wenwei, Lu, Lu, Lu, Ming, Zhang, Jubo, Chen, Jinhong
Format: Article
Language:English
Subjects:
Antigens
Care and treatment
Cell cycle
Development and progression
Epigenetics
Gene expression
Genetic aspects
Health aspects
Hepatitis
Hepatocellular carcinoma
Innovations
Liver cancer
Medical prognosis
Metastasis
Methyltransferases
Molecular targeted therapy
Mortality
Oncology
Patients
Phenotypes
Proteins
Statistical analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23
cites cdi_FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23
container_end_page 3673
container_issue 3
container_start_page 3665
container_title Oncology letters
container_volume 16
creator Lin, Zhifei
Jia, Huliang
Hong, Liang
Zheng, Yahui
Shao, Weiqin
Ren, Xudong
Zhu, Wenwei
Lu, Lu
Lu, Ming
Zhang, Jubo
Chen, Jinhong
description Histone methyltransferases are important determinants of the initiation and progression of hepatocellular carcinoma (HCC) and represent promising therapeutic targets. However, whether the expression profile of multiple histone methyltransferases represents a poorer prognosis is entirely unknown. The aim of the present study was to investigate the association between histone methylation and HCC phenotype, and the prognostic value of combining expression levels of SET domain-containing protein 8 (SET8) with protein arginine methyltransferase 5 (PRMT5) in patients with HCC following curative resection. The retrospective study included 195 consecutive patients who had undergone hepatectomy for HCC. Immunohistochemical staining for SET8 and PRMT5 was performed on paraffin-embedded tumor tissue microarrays. Expression was analyzed for correlations with clinicopathological features, marker co-expression and patients' survival by univariate and multivariate analyses. Positive SET8 expression was noted in 104 patients (53.3%), and was associated with PRMT5 expression (n=106, 54.4%, P
doi_str_mv 10.3892/ol.2018.9083
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A554637259</galeid><sourcerecordid>A554637259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23</originalsourceid><addsrcrecordid>eNptkltrFTEQxxdRbKl981kCgvjgHnM5u5u8CKXUCxQUrM8hm53spmSTY5Jt6ffxg5ql9dgjJg-5zG_-k5lMVb0keMO4oO-D21BM-EZgzp5Ux6QTtCaY06f7fbc9qk5TusZlNC3hvH1eHTFMaCe69rj69S2G0YeUrUZ23imdUTDo-8UVGsKsrK918Lms1o9oF0MG6xFHyg_7k4rjagY0Q57uXI7KJwNRJUANKvadyhZ8TujW5glNUM5Bg3OLUxFpFbX1JRIywblwu4bRSywuN4AiJNDZBv-iemaUS3D6sJ5UPz5eXJ1_ri-_fvpyfnZZ64bgXGuChYAtBqGZER1tYAusG_qe9pRB3_EWetINHeEFatpWCGI0iM5Az40eKDupPtzr7pZ-hkGXZ0fl5C7aWcU7GZSVhxZvJzmGG9li0RLBi8DbB4EYfi6QspxtWpNVHsKSJMWCUEZL6IK-_ge9Dkv0Jb2VainnXOC_1KgcSOtNKHH1KirPmmbbspLlqrX5D1XmALMtHwjGlvsDhzePHCZQLk8puGUtdjoE392DOoaUIph9MQiWawfK4OTagXLtwIK_elzAPfyn39hvOmvZaw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2096288890</pqid></control><display><type>article</type><title>Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection</title><source>Open Access: PubMed Central</source><creator>Lin, Zhifei ; Jia, Huliang ; Hong, Liang ; Zheng, Yahui ; Shao, Weiqin ; Ren, Xudong ; Zhu, Wenwei ; Lu, Lu ; Lu, Ming ; Zhang, Jubo ; Chen, Jinhong</creator><creatorcontrib>Lin, Zhifei ; Jia, Huliang ; Hong, Liang ; Zheng, Yahui ; Shao, Weiqin ; Ren, Xudong ; Zhu, Wenwei ; Lu, Lu ; Lu, Ming ; Zhang, Jubo ; Chen, Jinhong</creatorcontrib><description>Histone methyltransferases are important determinants of the initiation and progression of hepatocellular carcinoma (HCC) and represent promising therapeutic targets. However, whether the expression profile of multiple histone methyltransferases represents a poorer prognosis is entirely unknown. The aim of the present study was to investigate the association between histone methylation and HCC phenotype, and the prognostic value of combining expression levels of SET domain-containing protein 8 (SET8) with protein arginine methyltransferase 5 (PRMT5) in patients with HCC following curative resection. The retrospective study included 195 consecutive patients who had undergone hepatectomy for HCC. Immunohistochemical staining for SET8 and PRMT5 was performed on paraffin-embedded tumor tissue microarrays. Expression was analyzed for correlations with clinicopathological features, marker co-expression and patients' survival by univariate and multivariate analyses. Positive SET8 expression was noted in 104 patients (53.3%), and was associated with PRMT5 expression (n=106, 54.4%, P&lt;0.05). Immunohistochemical analysis demonstrated that high expression of SET8 and PRMT5 was significantly associated with poor overall survival (OS, P&lt;0.001) and time to recurrence (TTR, P&lt;0.001). Multivariate Cox analysis revealed that SET8 and PRMT5, along with vascular invasion, tumor size and tumor number, were independent prognostic factors for OS and TTR. The combination of SET8 and PRMT5 demonstrated an improved capacity to predict patient mortality and disease recurrence (P=0.002 and P=0.004, respectively), particularly for the prediction of early recurrence (P&lt;0.001). In conclusion, high expression of SET8 combined with PRMT5 was associated with a high rate of recurrence and poor survival in patients with HCC. The independent pattern of histone methylation represents a novel insight into tumor progression and therapeutic targets for HCC.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2018.9083</identifier><identifier>PMID: 30127976</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Antigens ; Care and treatment ; Cell cycle ; Development and progression ; Epigenetics ; Gene expression ; Genetic aspects ; Health aspects ; Hepatitis ; Hepatocellular carcinoma ; Innovations ; Liver cancer ; Medical prognosis ; Metastasis ; Methyltransferases ; Molecular targeted therapy ; Mortality ; Oncology ; Patients ; Phenotypes ; Proteins ; Statistical analysis</subject><ispartof>Oncology letters, 2018-09, Vol.16 (3), p.3665-3673</ispartof><rights>COPYRIGHT 2018 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright: © Lin et al. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23</citedby><cites>FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096198/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096198/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30127976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Zhifei</creatorcontrib><creatorcontrib>Jia, Huliang</creatorcontrib><creatorcontrib>Hong, Liang</creatorcontrib><creatorcontrib>Zheng, Yahui</creatorcontrib><creatorcontrib>Shao, Weiqin</creatorcontrib><creatorcontrib>Ren, Xudong</creatorcontrib><creatorcontrib>Zhu, Wenwei</creatorcontrib><creatorcontrib>Lu, Lu</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Zhang, Jubo</creatorcontrib><creatorcontrib>Chen, Jinhong</creatorcontrib><title>Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection</title><title>Oncology letters</title><addtitle>Oncol Lett</addtitle><description>Histone methyltransferases are important determinants of the initiation and progression of hepatocellular carcinoma (HCC) and represent promising therapeutic targets. However, whether the expression profile of multiple histone methyltransferases represents a poorer prognosis is entirely unknown. The aim of the present study was to investigate the association between histone methylation and HCC phenotype, and the prognostic value of combining expression levels of SET domain-containing protein 8 (SET8) with protein arginine methyltransferase 5 (PRMT5) in patients with HCC following curative resection. The retrospective study included 195 consecutive patients who had undergone hepatectomy for HCC. Immunohistochemical staining for SET8 and PRMT5 was performed on paraffin-embedded tumor tissue microarrays. Expression was analyzed for correlations with clinicopathological features, marker co-expression and patients' survival by univariate and multivariate analyses. Positive SET8 expression was noted in 104 patients (53.3%), and was associated with PRMT5 expression (n=106, 54.4%, P&lt;0.05). Immunohistochemical analysis demonstrated that high expression of SET8 and PRMT5 was significantly associated with poor overall survival (OS, P&lt;0.001) and time to recurrence (TTR, P&lt;0.001). Multivariate Cox analysis revealed that SET8 and PRMT5, along with vascular invasion, tumor size and tumor number, were independent prognostic factors for OS and TTR. The combination of SET8 and PRMT5 demonstrated an improved capacity to predict patient mortality and disease recurrence (P=0.002 and P=0.004, respectively), particularly for the prediction of early recurrence (P&lt;0.001). In conclusion, high expression of SET8 combined with PRMT5 was associated with a high rate of recurrence and poor survival in patients with HCC. The independent pattern of histone methylation represents a novel insight into tumor progression and therapeutic targets for HCC.</description><subject>Antigens</subject><subject>Care and treatment</subject><subject>Cell cycle</subject><subject>Development and progression</subject><subject>Epigenetics</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Hepatitis</subject><subject>Hepatocellular carcinoma</subject><subject>Innovations</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Methyltransferases</subject><subject>Molecular targeted therapy</subject><subject>Mortality</subject><subject>Oncology</subject><subject>Patients</subject><subject>Phenotypes</subject><subject>Proteins</subject><subject>Statistical analysis</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptkltrFTEQxxdRbKl981kCgvjgHnM5u5u8CKXUCxQUrM8hm53spmSTY5Jt6ffxg5ql9dgjJg-5zG_-k5lMVb0keMO4oO-D21BM-EZgzp5Ux6QTtCaY06f7fbc9qk5TusZlNC3hvH1eHTFMaCe69rj69S2G0YeUrUZ23imdUTDo-8UVGsKsrK918Lms1o9oF0MG6xFHyg_7k4rjagY0Q57uXI7KJwNRJUANKvadyhZ8TujW5glNUM5Bg3OLUxFpFbX1JRIywblwu4bRSywuN4AiJNDZBv-iemaUS3D6sJ5UPz5eXJ1_ri-_fvpyfnZZ64bgXGuChYAtBqGZER1tYAusG_qe9pRB3_EWetINHeEFatpWCGI0iM5Az40eKDupPtzr7pZ-hkGXZ0fl5C7aWcU7GZSVhxZvJzmGG9li0RLBi8DbB4EYfi6QspxtWpNVHsKSJMWCUEZL6IK-_ge9Dkv0Jb2VainnXOC_1KgcSOtNKHH1KirPmmbbspLlqrX5D1XmALMtHwjGlvsDhzePHCZQLk8puGUtdjoE392DOoaUIph9MQiWawfK4OTagXLtwIK_elzAPfyn39hvOmvZaw</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Lin, Zhifei</creator><creator>Jia, Huliang</creator><creator>Hong, Liang</creator><creator>Zheng, Yahui</creator><creator>Shao, Weiqin</creator><creator>Ren, Xudong</creator><creator>Zhu, Wenwei</creator><creator>Lu, Lu</creator><creator>Lu, Ming</creator><creator>Zhang, Jubo</creator><creator>Chen, Jinhong</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180901</creationdate><title>Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection</title><author>Lin, Zhifei ; Jia, Huliang ; Hong, Liang ; Zheng, Yahui ; Shao, Weiqin ; Ren, Xudong ; Zhu, Wenwei ; Lu, Lu ; Lu, Ming ; Zhang, Jubo ; Chen, Jinhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antigens</topic><topic>Care and treatment</topic><topic>Cell cycle</topic><topic>Development and progression</topic><topic>Epigenetics</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Hepatitis</topic><topic>Hepatocellular carcinoma</topic><topic>Innovations</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Methyltransferases</topic><topic>Molecular targeted therapy</topic><topic>Mortality</topic><topic>Oncology</topic><topic>Patients</topic><topic>Phenotypes</topic><topic>Proteins</topic><topic>Statistical analysis</topic><toplevel>online_resources</toplevel><creatorcontrib>Lin, Zhifei</creatorcontrib><creatorcontrib>Jia, Huliang</creatorcontrib><creatorcontrib>Hong, Liang</creatorcontrib><creatorcontrib>Zheng, Yahui</creatorcontrib><creatorcontrib>Shao, Weiqin</creatorcontrib><creatorcontrib>Ren, Xudong</creatorcontrib><creatorcontrib>Zhu, Wenwei</creatorcontrib><creatorcontrib>Lu, Lu</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Zhang, Jubo</creatorcontrib><creatorcontrib>Chen, Jinhong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Zhifei</au><au>Jia, Huliang</au><au>Hong, Liang</au><au>Zheng, Yahui</au><au>Shao, Weiqin</au><au>Ren, Xudong</au><au>Zhu, Wenwei</au><au>Lu, Lu</au><au>Lu, Ming</au><au>Zhang, Jubo</au><au>Chen, Jinhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection</atitle><jtitle>Oncology letters</jtitle><addtitle>Oncol Lett</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>16</volume><issue>3</issue><spage>3665</spage><epage>3673</epage><pages>3665-3673</pages><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>Histone methyltransferases are important determinants of the initiation and progression of hepatocellular carcinoma (HCC) and represent promising therapeutic targets. However, whether the expression profile of multiple histone methyltransferases represents a poorer prognosis is entirely unknown. The aim of the present study was to investigate the association between histone methylation and HCC phenotype, and the prognostic value of combining expression levels of SET domain-containing protein 8 (SET8) with protein arginine methyltransferase 5 (PRMT5) in patients with HCC following curative resection. The retrospective study included 195 consecutive patients who had undergone hepatectomy for HCC. Immunohistochemical staining for SET8 and PRMT5 was performed on paraffin-embedded tumor tissue microarrays. Expression was analyzed for correlations with clinicopathological features, marker co-expression and patients' survival by univariate and multivariate analyses. Positive SET8 expression was noted in 104 patients (53.3%), and was associated with PRMT5 expression (n=106, 54.4%, P&lt;0.05). Immunohistochemical analysis demonstrated that high expression of SET8 and PRMT5 was significantly associated with poor overall survival (OS, P&lt;0.001) and time to recurrence (TTR, P&lt;0.001). Multivariate Cox analysis revealed that SET8 and PRMT5, along with vascular invasion, tumor size and tumor number, were independent prognostic factors for OS and TTR. The combination of SET8 and PRMT5 demonstrated an improved capacity to predict patient mortality and disease recurrence (P=0.002 and P=0.004, respectively), particularly for the prediction of early recurrence (P&lt;0.001). In conclusion, high expression of SET8 combined with PRMT5 was associated with a high rate of recurrence and poor survival in patients with HCC. The independent pattern of histone methylation represents a novel insight into tumor progression and therapeutic targets for HCC.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>30127976</pmid><doi>10.3892/ol.2018.9083</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Oncology letters, 2018-09, Vol.16 (3), p.3665-3673
issn 1792-1074
1792-1082
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096198
source Open Access: PubMed Central
subjects Antigens
Care and treatment
Cell cycle
Development and progression
Epigenetics
Gene expression
Genetic aspects
Health aspects
Hepatitis
Hepatocellular carcinoma
Innovations
Liver cancer
Medical prognosis
Metastasis
Methyltransferases
Molecular targeted therapy
Mortality
Oncology
Patients
Phenotypes
Proteins
Statistical analysis
title Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A45%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20impact%20of%20SET%20domain-containing%20protein%208%20and%20protein%20arginine%20methyltransferase%205%20in%20patients%20with%20hepatocellular%20carcinoma%20following%20curative%20resection&rft.jtitle=Oncology%20letters&rft.au=Lin,%20Zhifei&rft.date=2018-09-01&rft.volume=16&rft.issue=3&rft.spage=3665&rft.epage=3673&rft.pages=3665-3673&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2018.9083&rft_dat=%3Cgale_pubme%3EA554637259%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c510t-c1099e40e9c3f9725e4e37dbb2b23eb786eb17d718e40566991fce97feb8fcd23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2096288890&rft_id=info:pmid/30127976&rft_galeid=A554637259&rfr_iscdi=true